N-[(1R)-1-[2-(cyclopropylmethoxy)-4-pyridinyl]propyl]-5-(2,4-dioxoimidazolidin-1-yl)pentane-1-sulfonamide

C20H30N4O5S — CID 155369984

IUPACN-[(1R)-1-[2-(cyclopropylmethoxy)-4-pyridinyl]propyl]-5-(2,4-dioxoimidazolidin-1-yl)pentane-1-sulfonamide
SMILESCC[C@@H](NS(=O)(=O)CCCCCN1CC(=O)NC1=O)c1ccnc(OCC2CC2)c1
InChIInChI=1S/C20H30N4O5S/c1-2-17(16-8-9-21-19(12-16)29-14-15-6-7-15)23-30(27,28)11-5-3-4-10-24-13-18(25)22-20(24)26/h8-9,12,15,17,23H,2-7,10-11,13-14H2,1H3,(H,22,25,26)/t17-/m1/s1
InChIKeyHONLAQORFVOVML-QGZVFWFLSA-N
MW438.55 g/mol
LogP1.96
Rot. Bonds13

About N-[(1R)-1-[2-(cyclopropylmethoxy)-4-pyridinyl]propyl]-5-(2,4-dioxoimidazolidin-1-yl)pentane-1-sulfonamide

N-[(1R)-1-[2-(cyclopropylmethoxy)-4-pyridinyl]propyl]-5-(2,4-dioxoimidazolidin-1-yl)pentane-1-sulfonamide (PubChem CID 155369984) has the molecular formula C20H30N4O5S and a molecular weight of 438.55 g/mol. Its IUPAC name is N-[(1R)-1-[2-(cyclopropylmethoxy)-4-pyridinyl]propyl]-5-(2,4-dioxoimidazolidin-1-yl)pentane-1-sulfonamide.

Molecular Properties

Compound NameN-[(1R)-1-[2-(cyclopropylmethoxy)-4-pyridinyl]propyl]-5-(2,4-dioxoimidazolidin-1-yl)pentane-1-sulfonamide
PubChem CID155369984
Molecular FormulaC20H30N4O5S
Molecular Weight438.55 g/mol
Exact Mass438.19
IUPAC NameN-[(1R)-1-[2-(cyclopropylmethoxy)-4-pyridinyl]propyl]-5-(2,4-dioxoimidazolidin-1-yl)pentane-1-sulfonamide
SMILESCC[C@@H](NS(=O)(=O)CCCCCN1CC(=O)NC1=O)c1ccnc(OCC2CC2)c1
InChIInChI=1S/C20H30N4O5S/c1-2-17(16-8-9-21-19(12-16)29-14-15-6-7-15)23-30(27,28)11-5-3-4-10-24-13-18(25)22-20(24)26/h8-9,12,15,17,23H,2-7,10-11,13-14H2,1H3,(H,22,25,26)/t17-/m1/s1
InChIKeyHONLAQORFVOVML-QGZVFWFLSA-N
XLogP1.96
TPSA117.70 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds13
Heavy Atoms30
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500438.55
LogP ≤ 51.96
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'hydantoin', 'substructure': 'N/A'}

Analyze N-[(1R)-1-[2-(cyclopropylmethoxy)-4-pyridinyl]propyl]-5-(2,4-dioxoimidazolidin-1-yl)pentane-1-sulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(1R)-1-[2-(cyclopropylmethoxy)-4-pyridinyl]propyl]-5-(2,4-dioxoimidazolidin-1-yl)pentane-1-sulfonamide?
The IUPAC name of N-[(1R)-1-[2-(cyclopropylmethoxy)-4-pyridinyl]propyl]-5-(2,4-dioxoimidazolidin-1-yl)pentane-1-sulfonamide (CID 155369984) is N-[(1R)-1-[2-(cyclopropylmethoxy)-4-pyridinyl]propyl]-5-(2,4-dioxoimidazolidin-1-yl)pentane-1-sulfonamide.
What is the SMILES notation for N-[(1R)-1-[2-(cyclopropylmethoxy)-4-pyridinyl]propyl]-5-(2,4-dioxoimidazolidin-1-yl)pentane-1-sulfonamide?
The canonical SMILES for N-[(1R)-1-[2-(cyclopropylmethoxy)-4-pyridinyl]propyl]-5-(2,4-dioxoimidazolidin-1-yl)pentane-1-sulfonamide is CC[C@@H](NS(=O)(=O)CCCCCN1CC(=O)NC1=O)c1ccnc(OCC2CC2)c1.
What is the InChIKey of N-[(1R)-1-[2-(cyclopropylmethoxy)-4-pyridinyl]propyl]-5-(2,4-dioxoimidazolidin-1-yl)pentane-1-sulfonamide?
The InChIKey is HONLAQORFVOVML-QGZVFWFLSA-N. The full InChI is InChI=1S/C20H30N4O5S/c1-2-17(16-8-9-21-19(12-16)29-14-15-6-7-15)23-30(27,28)11-5-3-4-10-24-13-18(25)22-20(24)26/h8-9,12,15,17,23H,2-7,10-11,13-14H2,1H3,(H,22,25,26)/t17-/m1/s1.
What are the key properties of N-[(1R)-1-[2-(cyclopropylmethoxy)-4-pyridinyl]propyl]-5-(2,4-dioxoimidazolidin-1-yl)pentane-1-sulfonamide?
N-[(1R)-1-[2-(cyclopropylmethoxy)-4-pyridinyl]propyl]-5-(2,4-dioxoimidazolidin-1-yl)pentane-1-sulfonamide has a molecular weight of 438.55 g/mol, XLogP of 1.96, 13 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(1R)-1-[2-(cyclopropylmethoxy)-4-pyridinyl]propyl]-5-(2,4-dioxoimidazolidin-1-yl)pentane-1-sulfonamide is sourced from PubChem (CID 155369984), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).